Stock Price
264.50
Daily Change
-3.30 -1.23%
Monthly
4.59%
Yearly
64.44%
Q2 Forecast
257.81

UCB reported EUR190.36M in Ordinary Share Capital for its fiscal semester ending in December of 2025.





Ordinary Share Capital Change Date
Alcon AG USD 487.4M 7.2M Dec/2025
Almirall EUR 214.79M 0 Dec/2025
Amarin USD 20.81M 13K Dec/2025
AstraZeneca USD 1.55B 206K Dec/2025
Bayer EUR 982.42M 0 Dec/2025
Galapagos EUR 65.9M 0 Dec/2025
Genmab DKK 61.62M 52K Dec/2025
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
GRIFOLS EUR 680.58M 846K Dec/2025
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Lonza CHF 68.64M 0 Dec/2025
Merck EUR 434.78M 0 Dec/2025
Novartis USD 1.91B 10.64M Dec/2025
Orion EUR 140.69M 0 Sep/2025
Recordati EUR 205.83M 270K Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
UCB EUR 190.36M 365.15K Dec/2025
Unibail Rodamco EUR 143.36M 109.64K Dec/2025